SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 185.78-1.4%2:49 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scusami who wrote (13923)1/30/1998 7:37:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
Scusami, I don't think that the inhaler news has anything to do with LGND's price. The inhaler news was also in the NY Times report and its not really new. LGND's diabetes compounds are oral. Inhaler news would have more of an effect on companies that rely on injected drugs (like LLY's insulin) and it would put more pressure on LLY to develop oral compounds like Targretin. I suspect that technical factors and margin calls are providing the recent selling pressure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext